Ronald J Weigel
Overview
Explore the profile of Ronald J Weigel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
1460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Tran A, Weigel R, Beck A
Am J Surg
. 2023 Nov;
229:106-110.
PMID: 37968147
Background: Rising incidence of papillary thyroid microcarcinomas (PTMC) has raised concerns for overdiagnosis. Utility of the American Thyroid Association Risk Stratification System (ATA-RSS) 2015 in predicting risk of disease recurrence...
13.
Suraju M, Freischlag K, Jacob D, Thompson D, McKeen A, Tran C, et al.
Surgery
. 2023 Oct;
175(3):735-742.
PMID: 37867105
Background: Mixed neuroendocrine-non-neuroendocrine neoplasms are a rare subtype of neuroendocrine neoplasm consisting of ≥30% each of neuroendocrine and non-neuroendocrine differentiation. Neuroendocrine carcinomas are poorly differentiated neuroendocrine tumors. The epidemiology and...
14.
Tithi T, Mo J, Borcherding N, Jo S, Kates H, Cho E, et al.
bioRxiv
. 2023 Sep;
PMID: 37745359
The mismatch repair (MMR) pathway is known as a tumor suppressive pathway and genes involved in MMR are commonly mutated in hereditary colorectal or other cancer types. However, the function...
15.
16.
Uhlmann R, Mott S, Curry M, Phadke S, Sugg S, Erdahl L, et al.
Ann Surg Oncol
. 2022 Aug;
29(10):6428-6437.
PMID: 35913669
Background: Lymphedema is a potential lifelong sequela of breast cancer treatment. We sought to: (1) evaluate the worry and knowledge of patients about lymphedema, (2) quantify patients reporting lymphedema education...
17.
Lyu C, Ye Y, Weigel R, Chen S
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406489
Cancer stem cells (CSCs) are a small subpopulation of cells within tumors that are resistant to anti-tumor therapies, making them a likely origin of tumor relapse after treatment. In many...
18.
Tran C, Goffredo P, Mott S, Hart A, You Y, Vauthey J, et al.
Surgery
. 2021 Dec;
171(3):657-665.
PMID: 34865865
Background: KRAS mutations, microsatellite instability, and tumor location have been found to be significant prognostic factors in colorectal cancer. The interaction between these variables and its effect on overall survival...
19.
Beck A, Rajan A, Landers S, Kelley S, Bellizzi A, Lal G, et al.
Surgery
. 2021 Aug;
171(1):245-251.
PMID: 34362588
Background: Tall cell variant of papillary thyroid carcinoma is an aggressive subtype of papillary thyroid carcinoma. We examined expression of cancer stem cell markers in tall cell variant compared with...
20.
Lyu C, Ye Y, Lensing M, Wagner K, Weigel R, Chen S
JCI Insight
. 2021 Aug;
6(18).
PMID: 34343132
GPCRs are highly desirable drug targets for human disease. Although GPCR dysfunction drives development and progression of many tumors, including breast cancer (BC), targeting individual GPCRs has limited efficacy as...